A new kind of cold sensor

All life forms need to continuously adapt to temperature changes to survive. Now, Weill Cornell Medicine investigators studying a bacterial protein have identified a new mechanism of sensing cold temperatures.

What does it mean to train an AI to speak like you?

Ultra-personalized AI for assisted communication risks muting aspects of the user’s identity and can breach privacy, according to a study from a Cornell Tech doctoral student who trained the technology on himself.

Cornell Tech announces the 2026 Startup Awards and the Inaugural Frontiers of AI Summit

As the 2025–26 academic year comes to a close, Cornell Tech will host a series of events throughout May showcasing student achievement, entrepreneurship, design, and the future of emerging technologies.

Around Cornell

Reverse engineering ketamine’s effects may lead to new antidepressants

Ketamine, an anesthetic, can provide immediate relief to some patients with treatment-resistant depression, but the effects are often short-lived.

T cells secrete DNA to help immune system fight cancer

Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body’s defense systems, according to a study led by investigators at Weill Cornell Medicine.

Extended reality tool lets dancers analyze movement

A Cornell doctoral student has helped develop a tool, DanXeReflect, that lets dancers use video and extended reality headsets to create an immersive environment for analyzing and refining their movements.

Nerves in skin can slow melanoma growth

Researchers found that nerves of the sympathetic nervous system are often abundant in melanomas, and can inhibit tumor growth by reducing local tumor-supportive macrophages.

Discovery of immune tolerance switch could yield better IBD treatments

Weill Cornell Medicine investigators made an unexpected finding that could open new avenues for therapies against inflammatory bowel disease, food allergy and other autoimmune conditions.

Understanding Hodgkin lymphoma cell origins could yield better diagnostics

Weill Cornell Medicine researchers have demonstrated, for the first time, that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an “identity crisis.”